Tesla Inc. Chief Executive Elon Musk accused him of asking "boring, boneheaded questions" in an earnings call seven years ago. But in fact, Bernstein's Toni Sacconaghi was a rare, clear-headed analyst ...

The S&P 500's 2.9% climb this week left it up 2% in January through Friday, according to FactSet data. The Invesco S&P 500 Equal Weight ETF RSP staged a larger 3.9% rally this week, for a year-to-date ...

There will be many moving parts for the U.S. economy and for financial markets as the second Trump administration makes its mark on regulation and trade policies. One of Trump's consistent opinions ...

'I have been a stay-at-home mom for the past five years and my husband is the sole breadwinner' ...

'I reaped financial rewards': I'm 51. My wife is 60. I have $4 million in savings. Should I give up my $300K advisory job to spend time with my wife? 'I worked in finance, top-tier private equity, for ...

1. He told you a half-truth. He may indeed end up with $500,000 in a retirement account by the time he gives up work. That could be based on a variety of factors, including the intention of working ...

U.S. stocks finished higher on Friday, the final trading day of Biden's term in office. All three major benchmarks posted weekly gains amid a retreat in Treasury yields. Investors were also looking ...

Another way to leave tax-free money to a surviving spouse is with life insurance. A small policy can put cash in the hands of a surviving spouse for funeral expenses and paying off debts. A bigger ...

The U.S. stock market just notched its best week since the presidential election. All three major U.S. stocks indexes advanced, with each of the Magnificent Seven tech stocks logging gains. The United ...

The Federal Trade Commission approved a consent order resolving antitrust concerns over Chevron's $53 billion acquisition of Hess. Under the final order, Chevron is prohibited from nominating, ...

The Massachusetts Development Finance Agency is offering $337 million in revenue bonds with proceeds slated to support UMass Memorial Health Care.

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.